Brian Satz - Sep 2, 2021 Form 4 Insider Report for Histogen Inc. (HSTO)

Role
Director
Signature
/s/ Richard W. Pascoe as attorney-in-fact for Brian Satz
Stock symbol
HSTO
Transactions as of
Sep 2, 2021
Transactions value $
$0
Form type
4
Date filed
9/3/2021, 04:06 PM
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +20K $0.00 20K Sep 2, 2021 Common Stock 20K $0.82 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person, a non-employee director of the Issuer, for his service as a director of the Issuer.
F2 The shares subject to this option become fully vested and exercisable on 5/26/2022, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.